COMMUNIQUÉS West-GlobeNewswire

Bionet Launches O’Pet Curv: A New Standard in Veterinary Wireless Monitoring
04/11/2025
TUSTIN, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Bionet America, Inc ., a leader in veterinary medical devices, has introduced the new O’Pet Curv, a compact, cloud-connected wireless monitoring system that allows [...]
Coloplast Finance B.V. - Annual Report, 2024/25
04/11/2025
Hereby please find the Annual Report 2024/25 for the group of Coloplast A/S. Attachment 11_2025_Annual_Report_2024-25
Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025
04/11/2025
CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will [...]
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
04/11/2025
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS ), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other [...]
Equillium to Participate in Upcoming Investor Conferences
04/11/2025
LA JOLLA, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Equillium , Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe [...]
Data Demonstrating Unique Benefits of Sotagliflozin in Diverse Patient Populations will be Presented at the Hypertrophic Cardiomyopathy Society and American Heart Association’s Sessions 2025 in New Orleans
04/11/2025
Study results further differentiate sotagliflozin from SGLT inhibitors and cardiac myosin inhibitors THE WOODLANDS, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced [...]
RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th
04/11/2025
MOUNTAIN VIEW, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a life-sciences company developing innovative targeted oncology therapies and commercializing [...]
Intelligent Bio Solutions Expects to Report Record Fiscal First Quarter 2026 Revenue of Over $1 Million, an Increase of Approximately 32% Sequentially and 28% Year-Over-Year
04/11/2025
C ompany Achieves Third Consecutive Quarter of Revenue Growth Revenue Increase of Approximately 32% Sequentially and 28% Year-Over-Year Driven by New Customer Accounts and Strong Cartridge and Reader Sales Cartridge and [...]
Sofwave Medical Reports Third Quarter 2025 Financial Results and Business Highlights
04/11/2025
— Record quarterly revenue in third quarter of $21.1M, +56% year-over-year growth; IFRS gross margin of 73.7% — Third quarter pulse recurring revenue of $8.3M, +55% year-over-year growth — First nine months revenue of $ [...]
NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025
04/11/2025
Financial results to be released before market open; Conference call to be conducted at 9:00 a.m. Eastern Time CARMEL, Ind., Nov. 04, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American [...]
CVRx to Present at the Jefferies Global Healthcare Conference in London
04/11/2025
MINNEAPOLIS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
Artelo Biosciences Announces Publication of Peer-Reviewed Article on Role of Fatty Acid Binding Proteins in Cancer
04/11/2025
Highlights Broad Development Potential of Proprietary Portfolio Targeting FABPs SOLANA BEACH, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company [...]
TELA Bio to Announce Third Quarter 2025 Financial Results
04/11/2025
MALVERN, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
InStride Health Announces Key Leadership Additions, Promotions to Enhance Payer Engagement, Technical Enablement, and Clinical Operations
04/11/2025
With new and elevated leaders, InStride is poised to scale its care model while maintaining its differentiated specialty care BOSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) -- InStride Health , a leading insurance-based [...]
Aligos Therapeutics to Present at Upcoming Investor Conferences
04/11/2025
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies [...]
24/7 Market News- Kraig Labs’ Spider Silk Breakthrough Poised to Rival Nylon’s 1939 Revolution
04/11/2025
The Dawn of a New Fiber Era DENVER, Nov. 04, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that in 1939, [...]
BiomX Announces Positive FDA Feedback Supporting Next-Generation Phage Cocktail Program for Diabetic Foot Infections
04/11/2025
New FDA feedback confirms clinical pathway for fixed multi-phage cocktail BX011, expanding development into diabetic foot infections (DFI) and unlocking a major commercial opportunity NESS ZIONA, Israel, Nov. 04, 2025 ( [...]
Tango Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
04/11/2025
– Data update from vopimetostat (TNG462) showed 2L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 months– – Combination studies with RAS(ON) inhibitors ongoing, data anticipated 2026 – – 49% ORR [...]
RESET™ Clinical Trial Demonstrates Superior Pain Relief with SPRINT® PNS Compared to Standard Interventional Management for Chronic Low Back Pain
04/11/2025
The study met its Primary Endpoint of pain relief and showed that SPRINT PNS delivered significant improvements in patient-centric secondary endpoints CLEVELAND, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Published in the [...]

Pages